Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,460,000 | 4,644,000 | 13,488,000 | 18,106,000 | 12,059,000 |
| Depreciation Amortization | 1,429,000 | 1,286,000 | 1,158,000 | 1,098,000 | 1,050,000 |
| Income taxes - deferred | 289,000 | -82,000 | -119,000 | -393,000 | -236,000 |
| Accounts receivable | 480,000 | 754,000 | 1,192,000 | -1,397,000 | -2,578,000 |
| Accounts payable and accrued liabilities | -39,000 | -430,000 | 47,000 | 226,000 | -289,000 |
| Other Working Capital | -939,000 | 5,108,000 | 1,546,000 | 1,495,000 | -518,000 |
| Other Operating Activity | 1,720,000 | 618,000 | -265,000 | 2,115,000 | 3,330,000 |
| Operating Cash Flow | $8,400,000 | $11,898,000 | $17,047,000 | $21,250,000 | $12,818,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 15,625,000 | -5,053,000 | -10,880,000 | -11,728,000 | -1,248,000 |
| PPE Investments | -924,000 | -590,000 | -748,000 | -747,000 | -557,000 |
| Net Acquisitions | N/A | -10,426,000 | N/A | N/A | N/A |
| Purchase Of Investment | -156,000 | N/A | -357,000 | N/A | -18,000 |
| Other Investing Activity | -190,000 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $14,355,000 | $-16,069,000 | $-11,985,000 | $-12,475,000 | $-1,823,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 8,985,000 | 6,249,000 | 10,686,000 | 10,475,000 |
| Debt Repayment | -6,250,000 | -1,811,000 | -1,981,000 | -997,000 | -4,805,000 |
| Common Stock Issued | 289,000 | 234,000 | 208,000 | 319,000 | 331,000 |
| Common Stock Repurchased | -2,900,000 | -954,000 | -11,001,000 | -10,002,000 | -5,349,000 |
| Dividend Paid | -2,971,000 | -2,731,000 | -2,455,000 | -1,874,000 | N/A |
| Other Financing Activity | -486,000 | -330,000 | -745,000 | -4,016,000 | -3,677,000 |
| Financing Cash Flow | $-12,318,000 | $3,393,000 | $-9,725,000 | $-5,884,000 | $-3,025,000 |
| Exchange Rate Effect | -85,000 | 137,000 | 41,000 | -67,000 | -56,000 |
| Beginning Cash Position | 7,588,000 | 8,229,000 | 12,851,000 | 10,027,000 | 2,113,000 |
| End Cash Position | 17,940,000 | 7,588,000 | 8,229,000 | 12,851,000 | 10,027,000 |
| Net Cash Flow | $10,352,000 | $-641,000 | $-4,622,000 | $2,824,000 | $7,914,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,400,000 | 11,898,000 | 17,047,000 | 21,250,000 | 12,818,000 |
| Capital Expenditure | -924,000 | -590,000 | -748,000 | -747,000 | -557,000 |
| Free Cash Flow | 7,476,000 | 11,308,000 | 16,299,000 | 20,503,000 | 12,261,000 |